An iron-dependent metabolic vulnerability underlies VPS34-dependence in RKO cancer cells

Marek J. Kobylarz(University of British Columbia), Beat Nyfeler(Novartis (Switzerland)), Walter Carbone(Novartis (Switzerland)), Dmitri Wiederschain(Boston Children's Hospital), Christophe Antczak(Novartis (Switzerland)), John Reece-Hoyes(University of Massachusetts Chan Medical School), Suchithra Menon(Novartis (Switzerland)), Judith Knehr(Novartis (Switzerland)), John Alford(The University of Melbourne), Kang Zhao, Joseph Loureiro(Johns Hopkins University), Gregory McAllister, Sarah Hevi(Beth Israel Deaconess Medical Center), Martin Beibel(Novartis (Switzerland)), John W. Annand(Novartis (United States)), Alicia Lindeman, Ellen O’Mahony(Novartis (United States)), Qiong Wang(China West Normal University), Carsten Russ(Broad Institute), Jonathan M. Goodwin(Casma Therapeutics (United States)), Leon O. Murphy(Casma Therapeutics (United States)), Guglielmo Roma(Novartis (Switzerland))
PLoS ONE
August 24, 2020
Cited by 13


Related Papers